From sensitivity to public health: integrating cfMeDIP-seq into early breast cancer detection strategies
Bei Feng, Tao Liu, Yan Feng, Juanjuan Huang, Jie Qin · 2024
Read From sensitivity to public health: integrating cfMeDIP-seq into early breast cancer detection strategies by Bei Feng, Tao Liu, Yan Feng, Juanjuan Huang, Jie Qin (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11606111.txt.
Description
Bei Feng and four co-authors wrote a 2024 letter to the editor about a blood test method for early breast cancer detection. The letter responds to a study that used a technique called cfMeDIP-seq to read methylation marks on free DNA floating in blood. That study showed the method can flag breast cancer risk in women carrying BRCA1 or BRCA2 mutations. The letter writers praise the work and offer ways to widen its public health value.
They suggest linking the test to community screening programs, so high-risk women are found before symptoms start. They also call for clear, personal ways to explain genetic risk, since raw risk numbers can frighten people. Health plans should add exercise, diet, and mental support, they argue. Cost studies are needed before wide rollout.
Catalog record
| CREATOR | Bei Feng, Tao Liu, Yan Feng, Juanjuan Huang, Jie Qin |
|---|---|
| YEAR | 2024 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 6 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |